Saturday 17 October 2026
Export PAIYY’s income statement to Excel — free account
Aesthetic Medical International Hldngs Group Ltd Sponsored ADR
PAIYY Healthcare Medical Care Facilities
In the quarter to June 2025, revenue grew 25,427.4% and EPS grew 76.8%, each against the same quarter a year earlier.
0.01
0.00
0.00%
Follow PAIYY
| Jun '25 | Jun '24 | Jun '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.04 | 0.17 | 0.54 | 0.50 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | |
P/B ratio |
25.91 | 14.01 | 11.07 | 7.53 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 47.36 | |
EV/Sales |
0.09 | 0.25 | 0.62 | 0.56 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(6.23) | (12.84) | (24.54) | (23.65) | |
EV/FCF |
(0.52) | (1.07) | (2.04) | (1.97) | |
Quick Ratio |
0.21 | 0.20 | 0.29 | 0.33 | |
Current Ratio |
0.24 | 0.24 | 0.35 | 0.38 | |
Net Debt/EBITDA |
(12.23) | (3.46) | (4.39) | 21.85 | |
Debt/Assets |
16.32% | 21.51% | 23.49% | 24.43% | |
Debt/Equity |
42.40 | 10.95 | 4.44 | 3.62 | |
Asset Turnover |
2.21 | 1.52 | 1.06 | 1.04 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
(1.09) | (2.89) | (1.22) | 0.35 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
41.52% | 48.76% | 50.04% | 45.12% | |
Intangible Assets out of Total Assets |
0.07 | 0.07 | 0.06 | 0.06 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(8.01) | (2.88) | (1.17) | (1.26) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(84.43%) | (51.54%) | (37.27%) | (31.35%) | |
Free Cash Flow Yield |
(404.36%) | (138.07%) | (56.20%) | (57.16%) | |
Revenue per Share |
1.01 | 1.04 | 0.95 | 0.56 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.08 | 0.13 | 0.27 | 0.44 | |
Shareholders Equity per Share |
0.01 | 0.03 | 0.09 | 0.16 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.01 | 0.03 | 0.09 | 0.16 | |
Free Cash Flow |
— | — | — | — | |
Working Capital |
(41.87) | (43.41) | (41.02) | (44.55) | |
Net Current Asset Value |
(54.17) | (57.03) | (56.88) | (60.44) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
6.44 | 5.75 | 6.34 | 6.26 | |
Average Payables |
6.11 | 6.37 | 5.83 | 6.00 | |
Average Inventory |
3.09 | 3.34 | 3.79 | 3.97 | |
Average Assets |
74.51 | 76.21 | 84.04 | 92.21 | |
Average Common Equity |
(9.22) | (8.05) | (11.29) | (11.21) |
Columns are period end dates